期刊文献+

高效液相色谱质谱联用检测血浆莎巴比星的基质效应影响因素 被引量:3

Factors influencing matrix effects of sabarubicin and its major metabolite in human plasma during liquid chromatography-tandem mass spectrometry analysis
原文传递
导出
摘要 目的:考察EDTA-K2和肝素锂抗凝血浆不同前处理方法和液相条件对于高效液相色谱质谱联用法检测莎巴比星及其代谢产物M3基质效应的影响。方法:以含不同抗凝剂的空白血浆配制低、中、高浓度样品,乙酸乙酯或氯仿液液萃取,流动相:A:0.1%甲酸水,B:乙腈,等度洗脱或梯度洗脱。莎巴比星、M3和内标多柔比星检测离子对分别为:m/z 644→130,m/z 646→333.2,m/z 544→360。采用提取后加入法,评价各浓度莎巴比星和M3在2种抗凝剂血浆中基质效应的差异以及方法优化对基质效应的影响。结果:低浓度时,EDTA-K2组莎巴比星和M3基质效应分别为123%和110%,肝素锂组分别为143%和160%。基质效应在不同抗凝剂组间差异有统计学意义(莎巴比星:P<0.05;M3:P<0.05)。氯仿萃取肝素锂抗凝血浆中莎巴比星低、中、高浓度基质效应分别为142%,94%和78%,M3分别为123%,102%和89%。梯度洗脱莎巴比星低、中、高浓度基质效应分别为108%,81%和73%,而M3分别为93%,83%和73%。最终低浓度莎巴比星和M3基质效应分别为85.4%和98.7%,高浓度分别为88.5%和96.0%。结论:肝素锂抗凝血浆中莎巴比星及其代谢物M3的基质增强效应更强,且在不同浓度存在较大差异,优化前处理方法以及液相方法后基质效应得到显著改善。 Objective: To investigate the influence of EDTA-K2 or lithium heparin anticoagulant plasma,different extraction agents and liquid chromatograph methods on matrix effects of sabarubicin and M3 during analysis by high performance liquid chromatography mass spectrometry. Methods: Prepared plasma samples of sabarubicin and M3 at 3 concentrations in plasmas containing different anticoagulants were extracted by ethyl-acetate or chloroform.Gradient elution or isocratic elution composed of A: 0. 1% formic acid water and B: acetonitrile were adopted,anda gradient elute were developed. Detection was performed by electrospray ionization( ESI) in the positive ionization mode by multiple reaction monitoring( MRM) of the transitions at m / z 644→130 for sabarubicin,m / z 646→333. 2for M3 and m / z 544→360 for internal standard doxorubicin. Post-extraction spiking method was adopted to investigate the impacts of these conditions on matrix effects of sabarubicin and M3. Results: At lower concentration,the matrix effects of sabarubicin and M3 in EDTA-K2 anticoagulant plasma were respectively 123% and 110%,while it is 143% and 160% in in lithium heparin anticoagulant plasma. There was a statistically significant difference between anticoagulant plasmas( sabarubixin: P 0. 05,M3: P 0. 05). Matrix effects for chloroform extracted sabarubicin and M3 at 3 concentrations in lithium heparin anticoagulant plasma were 142%,94% and 78% for sabarubicin,and 123%,102% and 89% for M3,respectively. After adoption of gradient elute,the matrix effects were 108%,81% and 73% for sabarubicin,and 93%,83% and 73% for M3,at 3 concentrations. The matrix effects in ultimate method were 85. 4% and 98. 7% for sabarubicin and M3 at low concentration,and 88. 5% and96. 0% at high concentration. Conclusion: The matrix effects are more serious for sabarubicin and M3 in lithium heparin anticoagulant plasma,which have large difference in multi-concentration. Improvement of pretreatment method and liquid chromatograph method could decrease matrix effects.
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第11期1241-1247,共7页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项资助项目(2012ZX09303012) 国家高技术研究发展计划(863计划)资助项目(2011AA02A110) 北京市科委重大项目(D141100000214003 D141100000214005)
关键词 基质效应 高效液相色谱质谱联用 抗凝剂 萃取剂 液相色谱法 生物样品分析 matrix effects HPLC-MS anticoagulant extraction agent liquid chromatograph method biological analysis
  • 相关文献

参考文献14

  • 1向平,沈敏,卓先义.液相色谱-质谱分析中的基质效应[J].分析测试学报,2009,28(6):753-756. 被引量:214
  • 2PANUWET P, HUNTER RE JR, D'SOUZA PE, et al. Biologi- cal matrix effects in quantitative tandem mass spectrometry-based analytical methods: advancing biomonitoring [ J ]. Crit Rev Anal Chem, 2016, 46(2): 93-105.
  • 3MEI H, HSIEH Y, NARDO C, et al. Investigetion of matrix effects in bioanalytical high-performance liquid chromatography/ tandem mass spectrometric assays: application to drug discovery [Jl. Rapid C un Mass Spect 2003,17( 1 ) :97 - 103.
  • 4BOS AM, DE VRIES EG, DOMBERNOVSKY P, et al. Pharma- cokinetics of MEN-10755, a novel anthracycline disaccharide an- alogue, in two phase I studies in adults with advanced solid tumours [ J ]. Cancer Chemother Pharmacol, 2001, 48 ( 5 ) :361 -369.
  • 5SCHRIJVERS D. Phase I study of MEN-10755, a new anthracy- cline in patients with solid tumours: a report from the European Organization for Research and Treatment of Cancer, Early Clini- cal Studies Group[J]. Ann Oncol, 2002, 13(3) : 385 -391.
  • 6MAZZINI S, SCAGLIONI L, ANIMATI F, et al. Interaction be- tween double helix DNA fragments and the new antitumor agent sabarubicin, Men10755[J]. Bioorg Med Chem, 2010, 18(4): 1497 - 1506.
  • 7MAZZELLA N, DELMAS F, DELEST B, et al. Investigation of the matrix effects on a HPLC-ESI-MS/MS method and application for monitoring triazine, phenylurea and chloroacetanilide concen- trations in fresh and estuarine waters [ J ]. J Environ Monit, 2009,11(1) :108 -115.
  • 8王立琦,曾振灵,束建花,王旭峰,贺利民,刘敏,张高奎.液相色谱-电喷雾串联质谱测定猪组织中β-兴奋剂残留的基质效应[J].分析化学,2012,40(9):1445-1449. 被引量:28
  • 9YE JH, PAO LH. Using visualized matrix effects to develop and improve lc-ms/ms bioanalytical methods, taking TRAM-34 as an example[Jl. PloS one, 2015, 10(4): e0118818.
  • 10KING R, BONFIGLIO R, FERNANDEZ-METZLER C, et al. Mechanistic investigation of ionization suppression in electrospray ionization[ J]. J Am Soc Mass Spectrom, 2000, 11 (11 ) : 942 - 950.

二级参考文献60

共引文献255

同被引文献48

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部